# GITR Inc.: Form D filings

GITR Inc., a biotechnology company in Cambridge, MA, filed 4 Form D notices with the SEC between 2012 and 2015. The latest, on May 8, 2015, reports $1.5 million sold of a $18.5 million offering to 1 investor.

Find out what GITR Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.

- [Watch for new raises](https://specstream.ai/workspace/ask?q=Tell%20me%20when%20GITR%20Inc.%20files%20a%20new%20Form%20D%20or%20reports%20more%20money%20sold%2C%20with%20the%20filing&src=data-formd&kind=alert&entity=GITR%20Inc.&page=%2Fdata%2Fform-d%2Fcompany%2Fgitr-inc-1538316)
- [Get founders and investors](https://specstream.ai/workspace/ask?q=For%20GITR%20Inc.%2C%20find%20what%20the%20company%20does%2C%20its%20website%2C%20the%20founders%20and%20executives%20with%20their%20LinkedIn%20and%20work%20email%2C%20its%20investors%20and%20every%20funding%20round%20with%20the%20amounts%2C%20its%20headcount%20and%20any%20reported%20valuation&src=data-formd&kind=record&entity=GITR%20Inc.&page=%2Fdata%2Fform-d%2Fcompany%2Fgitr-inc-1538316)

## The full lists

This record is a row of these lists. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email.

- [Form D filings in Massachusetts](https://specstream.ai/data/form-d/state/massachusetts): 1,533 rows, by operating companies, filed since November 1, 2024, $76.65, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/state/massachusetts
- [Form D filings in Biotechnology](https://specstream.ai/data/form-d/industry/biotechnology): 1,568 rows, by operating companies, filed since November 1, 2024, $78.40, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/industry/biotechnology

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

## Company details from the filing

- Address: c/o HealthCare Ventures LLC, 47 Thorndike Street, Suite B1-1, Cambridge, MA, 02141
- Phone: (617) 252-4343
- Industry: Biotechnology
- Entity type: Corporation
- Incorporated in: Delaware
- Year incorporated: 2011
- Revenue range: Decline to Disclose
- Exemptions claimed: Rule 506(b)
- SEC identifier (CIK): 1538316

## Form D filings

| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
| --- | --- | --- | --- | --- | --- | --- | --- |
| May 8, 2015 | New notice | $18,500,000 | $1,500,000 | $17,000,000 | 1 | Apr 24, 2015 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1538316/000114036115018554/0001140361-15-018554-index.htm) |
| Dec 21, 2012 | Amendment | $6,500,000 | $3,250,000 | $3,250,000 | 1 | Dec 21, 2011 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1538316/000114036112052376/0001140361-12-052376-index.htm) |
| Jun 12, 2012 | Amendment | $2,750,000 | $2,250,000 | $500,000 | 1 | Dec 21, 2011 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1538316/000114036112029568/0001140361-12-029568-index.htm) |
| Jan 4, 2012 | New notice | $2,000,000 | $1,250,000 | $750,000 | 1 | Dec 21, 2011 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1538316/000114036112000435/0001140361-12-000435-index.htm) |

## Executive officers and directors named in the filing

| Name | Role | Note in the filing |
| --- | --- | --- |
| Augustine Lawlor | Executive Officer, Director |  |
| Jeffrey Steinberg | Executive Officer, Director |  |
| Robert Steinberg | Executive Officer, Director |  |

## Other biotechnology companies in Massachusetts that filed recently

- [Zai Lab Ltd](https://specstream.ai/data/form-d/company/zai-lab-ltd-1704292) $249.9 million · Nov 9, 2026
- [AI3 Bio, Inc.](https://specstream.ai/data/form-d/company/ai3-bio-inc-2019875) offering · Nov 4, 2026
- [Tru Singular Health, Inc.](https://specstream.ai/data/form-d/company/tru-singular-health-inc-2158834) $1 million · Oct 30, 2026
- [511 Therapeutics, Inc.](https://specstream.ai/data/form-d/company/511-therapeutics-inc-1946264) $500,000 · Oct 30, 2026
- [Elucid Bioimaging Inc.](https://specstream.ai/data/form-d/company/elucid-bioimaging-inc-1585931) $56.2 million · Oct 27, 2026
- [OrthoIQ, Inc.](https://specstream.ai/data/form-d/company/orthoiq-inc-2154488) $1.1 million · Oct 23, 2026

[Every Form D from the week of May 4, 2015](https://specstream.ai/data/form-d/week/2015-05-04) · [All recent filings in Massachusetts](https://specstream.ai/data/form-d/state/massachusetts) · [All recent Biotechnology filings](https://specstream.ai/data/form-d/industry/biotechnology)

Read from SEC EDGAR. Amount sold is what GITR Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under [CC BY 4.0](https://creativecommons.org/licenses/by/4.0/).